For instance, porcupine o-acyltransferase (PORCN) inhibitors under development for oncology reduce tumor growth but also impair bone integrity, lowering bone mineral density and increasing fracture risk through Wnt pathway inhibition (Xi and Chen, 2014). The gene discussed is PORCN; the disease is neoplasm.